The global hydroxyapatite market size is anticipated to reach USD 3.92 billion by 2030 and is anticipated to expand at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The hydroxyapatite market is driven by its wide use in bone grafts, dental coatings, and orthopedic implants due to its biocompatibility and osteoconductive properties. The increasing prevalence of osteoporosis, arthritis, and tooth loss, particularly among aging populations, is driving demand.
The nano-sized segment dominated the market with a revenue share of 58.3% in 2024, during the forecast period. The nano-sized segment is growing due to its enhanced bioactivity, high surface area, and superior osteoconductive properties, making it ideal for biomedical applications such as bone grafts, dental coatings, and drug delivery systems. Increasing demand in regenerative medicine, orthopedics, and personal care products is driving market expansion.
The orthopedics segment dominated the market with a revenue share of 56.3% in 2024, during the forecast period. The orthopedics segment is expected to grow as product market is widely used in bone grafts, implants, and coatings for joint replacements due to its biocompatibility and osteoconductive properties. Rising cases of osteoporosis, arthritis, and bone fractures, particularly among aging populations, are fueling demand. Advancements in 3D printing and regenerative medicine are further enhancing hydroxyapatite’s role in orthopedic applications.
Asia Pacific dominated the market with a market share of 50.7% in 2024, during the forecast period. The Asia Pacific market is expanding due to increasing demand in orthopedic and dental implants, driven by a rising aging population and improved healthcare infrastructure. Countries such as China, Japan, and India are investing in medical advancements, boosting hydroxyapatite applications in regenerative medicine and biomaterials.
Some of the prominent players in the cryogenic gases market include APS Materials Inc., Zimmer Biomet, Bio-Rad Laboratories Inc., CGbio, Fluidinova, The Lubrizol Corporation, Granulab Sdn. Bhd., SigmaGraft Biomaterials, Berkeley Advanced Biomaterials (GNI Group Ltd), and Taihei Chemica Industrial Co. Ltd.
Request a free sample copy or view report summary: Hydroxyapatite Market Report
The nano-sized segment is expected to have the largest revenue share of 58.3% in 2024. due to its superior biocompatibility, high surface area, and enhanced bioactivity, making it ideal for orthopedic, dental, and drug delivery applications. Advancements in nanotechnology and biomedical research are driving demand, particularly in bone regeneration and implant coatings.
Asia Pacific is the dominant region for the aluminum hydroxide market with a revenue share of 50.7% in 2024. The Asia Pacific hydroxyapatite market is growing due to growing consumer awareness of personal care products incorporating hydroxyapatite, such as toothpaste and skincare, is further supporting market growth. However, regulatory challenges and fluctuating raw material costs may impact market expansion.
In May 2023, HAPPE Spine, an orthopedic implants manufacturer, and medical device company, announced that one of its products, INTEGRATE-C Interbody Fusion System, got 510(k) clearance from the FDA. This system is the first interbody fusion cage fully integrated with hydroxyapatite and designed with porosity, promoting bone ingrowth and enhancing cell signaling. It is intended to be radiolucent and radiovisible, enhancing imaging during and after surgery. The significance of this advancement is that the system offers various sizes and angles to suit different patient anatomies.
Grand View Research has segmented the global hydroxyapatite market on the basis of product, end-use, and region:
Hydroxyapatite Product Outlook (Volume, Kilotons; Revenue, USD Billion, 2018 - 2030)
Nano-sized
Micro-sized
Greater than Micrometers
Hydroxyapatite End -use Outlook (Volume, Kilotons; Revenue, USD Billion, 2018 - 2030)
Dental Care
Plastic Surgery
Orthopedics
Other End Use
Hydroxyapatite Region Outlook (Volume, Kilotons; Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
South Africa
List of Key Players in the Hydroxyapatite Market
APS Materials Inc.
Berkeley Advanced Biomaterials (GNI Group Ltd)
Bio-Rad Laboratories Inc.
CGbio
Fluidinova
The Lubrizol Corporation
Granulab Sdn. Bhd.
SigmaGraft Biomaterials
Taihei Chemica Industrial Co. Ltd.
Zimmer Biomet
"The quality of research they have done for us has been excellent..."